Chemotherapy-induced cardiomyopathy

Expert Rev Cardiovasc Ther. 2011 Feb;9(2):231-43. doi: 10.1586/erc.10.188.

Abstract

Improvement in cancer therapy has led to an increasing number of cancer survivors, some of whom may suffer from the cardiotoxic effects of chemotherapy. Cardiomyopathy can occur years after completion of the chemotherapy and it is important to recognize this early, as complete recovery of cardiac function is possible in some cases. In this article we will review chemotherapy-induced cardiomyopathy and discuss its treatment options.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Biomarkers / blood
  • Cardiomyopathies / chemically induced*
  • Cardiomyopathies / complications
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / therapy*
  • Drug Monitoring / methods
  • Early Diagnosis
  • Heart Diseases / chemically induced*
  • Heart Diseases / complications
  • Heart Diseases / diagnosis
  • Heart Diseases / therapy*
  • Heart Failure / chemically induced
  • Heart Failure / complications
  • Heart Failure / diagnosis
  • Heart Failure / therapy
  • Humans
  • Neoplasms / blood
  • Neoplasms / complications
  • Neoplasms / drug therapy*
  • Ventricular Dysfunction, Left / chemically induced
  • Ventricular Dysfunction, Left / complications
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / therapy

Substances

  • Antineoplastic Agents
  • Biomarkers